| Specific inhibition of carbonic anhydrase IX activity enhances the in vivo therapeutic effect of tumor irradiation L Dubois, S Peeters, NG Lieuwes, N Geusens, A Thiry, S Wigfield, F Carta, ... Radiotherapy and Oncology 99 (3), 424-431, 2011 | 211 | 2011 |
| A comparative study of the hypoxia PET tracers [18F] HX4,[18F] FAZA, and [18F] FMISO in a preclinical tumor model SGJA Peeters, CML Zegers, NG Lieuwes, W van Elmpt, J Eriksson, ... International Journal of Radiation Oncology* Biology* Physics 91 (2), 351-359, 2015 | 199 | 2015 |
| TH-302 in Combination with Radiotherapy Enhances the Therapeutic Outcome and Is Associated with Pretreatment [18F]HX4 Hypoxia PET Imaging SGJA Peeters, CML Zegers, R Biemans, NG Lieuwes, ... Clinical cancer research 21 (13), 2984-2992, 2015 | 122 | 2015 |
| Targeting carbonic anhydrase IX by nitroimidazole based sulfamides enhances the therapeutic effect of tumor irradiation: a new concept of dual targeting drugs L Dubois, SGJA Peeters, SJA Van Kuijk, A Yaromina, NG Lieuwes, ... Radiotherapy and Oncology 108 (3), 523-528, 2013 | 97 | 2013 |
| New ways to image and target tumour hypoxia and its molecular responses LJ Dubois, R Niemans, SJA van Kuijk, KM Panth, NK Parvathaneni, ... Radiotherapy and Oncology 116 (3), 352-357, 2015 | 61 | 2015 |
| Current preclinical and clinical applications of hypoxia PET imaging using 2-nitroimidazoles SG Peeters, CM Zegers, A Yaromina, W Van Elmpt, L Dubois, P Lambin QJ Nucl Med Mol Imaging 59 (1), 39-57, 2015 | 58 | 2015 |
| [18F]VM4-037 MicroPET Imaging and Biodistribution of Two In Vivo CAIX-Expressing Tumor Models SGJA Peeters, L Dubois, NG Lieuwes, D Laan, M Mooijer, RC Schuit, ... Molecular imaging and biology 17, 615-619, 2015 | 40 | 2015 |
| Preclinical assessment of efficacy of radiation dose painting based on intratumoral FDG-PET uptake D Trani, A Yaromina, L Dubois, M Granzier, SGJA Peeters, R Biemans, ... Clinical Cancer Research 21 (24), 5511-5518, 2015 | 39 | 2015 |
| A phase 1 ‘window-of-opportunity’trial testing evofosfamide (TH-302), a tumour-selective hypoxia-activated cytotoxic prodrug, with preoperative chemoradiotherapy in oesophageal … RTHM Larue, L Van De Voorde, M Berbée, WJC van Elmpt, LJ Dubois, ... BMC cancer 16, 1-8, 2016 | 31 | 2016 |
| Dosimetric evaluation of radionuclides for VCAM-1-targeted radionuclide therapy of early brain metastases N Falzone, NL Ackerman, L de la Fuente Rosales, MA Bernal, X Liu, ... Theranostics 8 (1), 292, 2018 | 21 | 2018 |
| Microbubbles Containing Lysolipid Enhance Ultrasound‐Mediated Blood–Brain Barrier Breakdown In Vivo O Vince, S Peeters, VA Johanssen, M Gray, S Smart, NR Sibson, E Stride Advanced Healthcare Materials 10 (3), 2001343, 2021 | 11 | 2021 |
| (In) organic anions as carbonic anhydrase inhibitors N Krall, F Pretto, W Decurtins, SU Rehman, ZH Chohan, F Gulnaz, ... Angew Chem Int Ed Engl 53, 4231-5, 2014 | 7 | 2014 |
| Inhibition of the archaeal β-class (Cab) and γ-class (Cam) carbonic anhydrases N Krall, F Pretto, W Decurtins, SU Rehman, ZH Chohan, F Gulnaz, ... Angew Chem Int Ed Engl 53, 4231-5, 2014 | 5 | 2014 |
| Synthesis and Radiosynthesis of Prospective 2-Nitroimidazole Hypoxia PET Tracers via Thiazolidine Ligation with 5-Fluorodeoxyribose (FDR) M Musolino, S Dall’Angelo, M Zanda SynOpen 1 (01), 0173-0179, 2017 | 2 | 2017 |
| PV-0039: Outcome of elderly NSCLC patients treated with isotoxic RT dose-escalation using IMRT (NCT01166204) J Van Loon, D De Ruysscher, S Peeters, K Verhoeven, G Bootsma, ... Radiotherapy and Oncology 127, S15-S16, 2018 | 1 | 2018 |
| Abstract B144: Hypoxia imaging with [18F] HX4 PET compared with [18F] FMISO and [18F] FAZA: From preclinical to clinical studies. S Peeters, C Zegers, N Lieuwes, W van Elmpt, F Hoebers, H Sharifi, ... Molecular Cancer Therapeutics 12 (11_Supplement), B144-B144, 2013 | 1 | 2013 |
| Toward the development of a novel drug using engineered peptides designed for EGFR-mediated drug delivery of an apoptosis inducer in anaplastic thyroid carcinoma ZC Kahvecioglu, S Vandecasteele, M Bougard, S Peeters, A Daubry, ... Télévie Seminar, 2024 | | 2024 |
| Targeted opening of the blood-brain barrier using VCAM-1 functionalised microbubbles and “whole brain” ultrasound VA Johanssen, JL Ruan, O Vince, A Thomas, S Peeters, MS Soto, J Buck, ... Theranostics 14 (10), 4076, 2024 | | 2024 |
| Innovative drug delivery system using EGFR-targeted engineered peptides in anaplastic thyroid cancer treatment ZC Kahvecioglu, S Vandecasteele, M Bougard, S Peeters, A Daubry, ... PhD Day SFMBBM 2023, 2023 | | 2023 |
| PO-1024: Fractionated RT is equally effective but less toxic than SBRT for central early-stage NSCLC M Leenders, S Peeters, J Van Loon, A Van Baardwijk, B Reymen, ... Radiotherapy and Oncology 152, S546, 2020 | | 2020 |
